Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The genomic landscape of male breast cancers
    Meeting Abstract

    Piscuoglio, S.; Murray, M.; Ng, C. K. Y.; Rocco, E. G.; Martelotto, L. G.; Bidard, F. C.; Eberle, C. A.; Fusco, N.; Sakr, R. A.; De Mattos-Arruda, L.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Prognostic and predictive implications of monosomy 17 in curable HER2-amplified breast cancer
    Meeting Abstract

    Page, D.; Wen, Y. H.; Dure, D.; Hudis, C.; Brogi, E.; Mcarthur, H.
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Integrated immunologic assessment of tumor infiltrating lymphocytes (TILs) and peripheral blood to assess synergy of cryoablation (cryo) plus ipilimumab (ipi) in early stage breast cancer (ESBC) patients (pts)
    Meeting Abstract

    Page, D.; Yuan, J. D.; Diab, A.; Dong, Z.; Ginsberg, A.; Wong, P.; Emerson, R.; Redmond, D.; Blum, B.; Mu, Z.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Mutational landscape of metaplastic breast carcinomas
    Meeting Abstract

    Ng, C. K. Y.; Weigelt, B.; Piscuoglio, S.; Wen, Y. H.; De Filippo, M. R.; Martelotto, L. G.; Natrajan, R.; Lim, R.; Brogi, E.; Norton, L.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Alliance A011106: ALTernate approaches for clinical stage II or III Estrogen Receptor positive breast cancer NeoAdjuvant TrEatment (ALTERNATE) in postmenopausal women: A phase III study
    Meeting Abstract

    Ma, C. X.; Suman, V.; Leitch, A. M.; Sanati, S.; DeSchryver, K.; Unzeitig, G. W.; Haluska, P.; Watson, M.; Hahn, O.; Zujewski, J. A.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • A phase I clinical trial of ganetespib (heat shock protein 90 inhibitor) in combination with paclitaxel and trastuzumab in human epidermal growth factor receptor-2 positive (HER2+) metastatic breast cancer
    Meeting Abstract

    Jhaveri, K.; Cadoo, K.; Chandarlapaty, S.; Teplinsky, E.; Speyer, J.; D'Andrea, G.; Patil, S.; Haque, S.; Friedman, K.; Heese, S.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Both metabolic syndrome and statin use are more common in women with breast inflammation
    Meeting Abstract

    Iyengar, N. M.; Gucalp, A.; Zhou, X. K.; Howe, L. R.; Morris, P. G.; Giri, D.; Subbaramaiah, K.; Bhardwaj, P.; Park, S. S.; Pollak, M.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • A randomized, multicenter, phase II study of ipatasertib (Ipat, GDC-0068), an inhibitor of Akt, in combination with paclitaxel (Pac) as front-line treatment for patients (pts) with metastatic triple-negative breast cancer (TNBC)
    Meeting Abstract

    Isakoff, S. J.; Kim, S. B.; Im, S. A.; Dent, R. A.; Traina, T. A.; Valero, V.; Saura, C.; Yalamanchili, S.; Patel, P.; Oliveira, M.
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Impact of tumor-infiltrating B-cell clonal diversity on response to neoadjuvant therapy in triple negative and HER2+breast cancer treated on CALGB (Alliance) 40601 and 40603
    Meeting Abstract

    Iglesia, M. D.; Vincent, B. G.; Serody, J. S.; Carey, L. A.; Barry, W. T.; Sikov, W. M.; Hudis, C. A.; Winer, E. M.; Perou, C. M.
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Mutational analysis of CALGB 40601 (Alliance), a neoadjuvant phase III trial of weekly paclitaxel (T) and trastuzumab (H) with or without lapatinib (L) for HER2-positive breast cancer
    Meeting Abstract

    Hoadley, K. A.; Barry, W. T.; Pitcher, B. N.; Parker, J. S.; Wilkerson, M. D.; Irvin, W.; Henry, N. L.; Tolaney, S. M.; Dang, C.; Krop, I. E.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save